Condition
Unresectable Breast Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Unresectable Breast Carcinoma clinical trials that are recruiting, at sites in 11 countries (most in United States (4), Australia (1), Canada (1)). By phase: Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 11Countries
Newest Unresectable Breast Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety of combining pidnarulex (CX-5461) with trastuzumab deruxtecan for HER2-positive, HER2-low/ultralow breast and other HER2-expressing solid tumors | Phase 1 | Boston, Massachusetts and 1 other locations | Recruiting | Aug 22, 2025 |
| Finding the best dose of BNT323 and BNT327 for advanced breast cancer | Phase 1/2 | Beverly Hills, California and 83 other locations | Recruiting | Feb 14, 2025 |
| Understanding the in-home hospice experience for breast cancer patients | — | Boston, Massachusetts | Recruiting | Jul 18, 2024 |
| Combining two anti-cancer drugs for patients with advanced tumors | Phase 1 | Los Angeles, California and 6 other locations | Recruiting | May 13, 2022 |
All recruiting trials (4)
-
Safety of combining pidnarulex (CX-5461) with trastuzumab deruxtecan for HER2-positive, HER2-low/ultralow breast and other HER2-expressing solid tumors
This trial tests whether adding pidnarulex to trastuzumab deruxtecan is safe and finds the best dose for adults with HER2-positive, HER2-low/ultralow, or other HER2-expressing advanced or metastatic breast and solid tumors.
-
Finding the best dose of BNT323 and BNT327 for advanced breast cancer
This study is testing the best dose of a new combination treatment for advanced breast cancer to see how well it works and if it's safe for patients.
-
Understanding the in-home hospice experience for breast cancer patients
This study looks at how to improve hospice care for breast cancer patients at home by checking in with them and their caregivers through telehealth to see what works best.
-
Combining two anti-cancer drugs for patients with advanced tumors
This study is testing a new combination of two anti-cancer drugs to see if it can help teenagers and adults with advanced tumors feel better and improve their treatment options.
Related topics
Quick answers
How many Unresectable Breast Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (4 trials), Australia (1 trial), Canada (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.